netFormulary Bradford Teaching Hospitals NHS
NHS Foundation Trust Formulary  
 Search
 Results

Looking for Adalimumab found 15 matches

Open monograph to display formulary status BNF Category
  Adalimumab  (Amgevita)
(Gastro)
Gastro-intestinal system - Cytokine inhibitors - 01.05.03
  Adalimumab  (Amgevita) Musculoskeletal and joint diseases - Cytokine modulators - 10.01.03
  Adalimumab  (Amgevita)
(Amgevita is formulary. Humira can be used after approval from DTC)
Skin - Drugs affecting the immune response - 13.05.03
  Adalimumab  (Amgevita)
(Dermatology)
Skin - Drugs affecting the immune response - 13.05.03
  Etanercept  (Benepali)
(Dermatology)
Skin - Drugs affecting the immune response - 13.05.03
  Golimumab  (Simponi )
(Gastro)
Gastro-intestinal system - Cytokine inhibitors - 01.05.03
  Infliximab  (Remsima)
(Gastro)
Gastro-intestinal system - Cytokine inhibitors - 01.05.03
  Infliximab  (Remsima)
(Dermatology)
Skin - Drugs affecting the immune response - 13.05.03
  Restricted Drug Ustekinumab  (Stelara) Skin - Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in subsection NICE TA130: Rheumatoid arthritis - adalimumab, etanercept and infliximab (10.01.03)
link in subsection NICE TA143: Ankylosing spondylitis - adalimumab, etanercept and infliximab (10.01.03)
link in subsection NICE TA199: Psoriatic arthritis - etanercept, infliximab and adalimumab (10.01.03)
link in drug section NICE TA199: Psoriatic arthritis - etanercept, infliximab and adalimumab  (10.01.03)
link in drug section NICE TA199: Psoriatic arthritis - etanercept, infliximab and adalimumab  (10.01.03)
link in drug section TA375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed (10.01.03)


 

netFormulary